Medlinker
PrivateLast Round
Series E
Dec 30, 2020
Est. Valuation
$3.93B
Total Funding Raised
$767.09M
Company Overview
Medlinker is a healthcare technology company that operates an AI-driven medical platform providing chronic disease management, expert doctor consultations, and digital health services.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medlinker Comparables
Compare Medlinker with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Miaoshou Doctor | 86% | |
| WeDoctor | 84% | |
| ClouDr Group | 84% |
Medlinker Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Dec 30, 2020 | ||||
| Series D | Jul 31, 2018 | ||||
| Series C | Dec 6, 2017 | ||||
| Series B | Sep 7, 2015 | ||||
| Series A | Feb 1, 2015 | ||||
Angel | Aug 1, 2014 |
Medlinker Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| PreAngel | Angel |
| Ceyuan Ventures | Series A, Angel |
| Agricultural Bank of China International | Series D |
| CCIC Capital | Series D |
| 招银国际金融有限公司 | Series B |
| Huasheng Capital | Series C, Series B, Series D |
| China Investment Corporation | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 30, 2020
$514M round led by Sino Biopharmaceutical.
- Jul 30, 2018
$147M round led by China Investment Corporation
Medlinker Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Medlinker's valuation, stock price, and market status.
Is Medlinker a public or private company?
Medlinker is a private company.
What is the current stock price of Medlinker?
Medlinker is a private company, so its shares have no public market price. Caplight tracks Medlinker's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Medlinker worth (valuation)?
Medlinker's valuation is estimated at $3.9B based on funding round data.
Can I buy Medlinker stock?
Medlinker shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Medlinker's last funding round?
Medlinker's most recent funding round was Series E on December 30, 2020.
Who are the main investors in Medlinker?
Key investors in Medlinker include CCIC Capital, China Investment Corporation, HongShan Capital Group (HSG).
Will Medlinker IPO soon?
No public IPO plans have been announced for Medlinker.
How can I track Medlinker secondary market activity?
Caplight tracks bids, offers, and trades in Medlinker's shares on secondary markets.